BYM338

Novartis aims to show strength with muscle wasting drug
Yahoo/Reuters
Fri, 12/6/13 - 10:24 am
muscle wasting
Novartis
sporadic inclusion body myositis
BYM338
MorphoSys
"Breakthrough Therapy" Status Could Hasten Novartis Drug Review
Motley Fool
Wed, 08/21/13 - 09:05 am
Novartis
breakthrough therapies
BYM338
sporadic inclusion body myositis
FDA